SynthesisJournal of clinical hypertension (Greenwich, Conn.)2022

Incidence and risk of hypertension with lenvatinib in treatment of solid tumors: An updated systematic review and meta-analysis.

Hongxiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.